| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.34 | 9e-07 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.31 | 9e-06 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.098 | 0.001 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |